Eskimo means eater of raw meat and Eskimos ate raw not only the flesh but also the viscera, teeth, skin and fur! In this way they obtained a considerable amount of 'fibre', in the sense of non-digestible material. But their freedom from constipation and its associated disorders may have been due in part to the laxative properties of unabsorbed fat since their fat intakes were extremely high. Professor Sinclair has made famous the Eskimos' freedom from arterial disease which he links to the marked reluctance of their blood to clot. This in turn is explained by their exceptionally high intake of essential fatty acids. The arcane biochemistry behind this story was explained in Professor Sinclair's inimitable way. There is one snag for the enthusiast who may wish to eat like an Eskimo: this is erucic acid, the C22:1Q9 fatty acid found in rapeseed oil, whose isomer ceteleic acid is plentiful in the Eskimo diet. Erucic The scientific meeting lasted for three days, with sessions on inflammatory bowel disease, carcinoma of colon and rectum, the pelvic floor and rectal prolapse, as well as four sessions for free papers.
The first morning was spent considering Crohn's disease, with several speakers from Madrid presenting different aspects of their well documented series of 160 cases. Clinical features of the disease were introduced by P Schofield from Manchester, and by C Chantar from Madrid, speaking particularly of extraintestinal manifestations. One-third of all cases in the Madrid series had extraintestinal problems in joints, skin, mouth or eyes, biliary and renal lithiasis or amyloid disease. In addition, several cases of massive haemorrhage from Crohn's disease were presented by A Abad from Barcelona. This aspect of Crohn's disease is not one commonly reported in Britain. The pathology of Crohn's disease was reviewedbyJMenendez from Madrid andJHaboubi from Manchester. Dr Haboubi emphasized the problem the pathologist has in making the diagnosis on small colonic rectal biopsies where submucosa is not included in the specimen. Both stressed that granulomata are not necessarily pathognomonic of Crohn's disease, as they may be due to a foreign body reaction to faeces in ischaemic colitis or to extravasated mucus in ulcerative colitis and campylobacter colitis.
In considering surgical treatment, aspects of stricturoplasty and ileorectal anastomosis for Crohn's disease, and ileoanal pouch anastomosis for ulcerative colitis were reviewed. S Gomez from Vitoria presented three cases in which multiple intestinal myotomies had been used to reduce bowel motility and frequency in association with J pouches. On the other hand, M Gassul from Barcelona drew attention to the nutritional problems in Crohn's disease and suggested that enteral tube feeding would not only improve the nutritional status but could also reduce the need for surgery.
The Spanish experience of Crohn's disease in its presentation, prognosis and management appears to be similar to ours and, as in the UK, it appears to be becoming more common.
On the next morning attention was turned to the treatment and follow up of colorectal cancer. Bowel preparation for surgery was considered first. F Parilla from Murcia, favouring antegrade lavage, had now settled for oral mannitol as satisfactory and well tolerated; it seemed, on a show of hands, that this was the most popular method with the Spanish surgeons. British delegates, however, pointed out the problems of bacterial overgrowth with mannitol, and reported that in the UK most had now changed to a sodium picosulphate purge. After A SitgesCreus had given an overview of surgical treatment, R James from Manchester attempted to define the place of radiotherapy. He related the indications for radiotherapy to preoperative clinical staging of the growth, in which fixity of the growth is assessed by digital examination. He suggested that with mobile growths (Stage I) radical surgery alone should be used. With a tethered growth (Stage II) preoperative radiotherapy should be given. Where distant metastases are detected (Stage III), then the choice of surgery, radiotherapy or chemotherapy will depend upon the particular problem needing palliation. The place of chemotherapy was reviewed by P Cassell from Windsor. It seems that the days of effective systemic chemotherapy for colorectal cancer are not yet here, but for the future the development of inmmunotoxins and chemotherapy sensitivity testing may bring better news. The value of follow up of 0141-0768/86/ 060370-02/$02.00/0 i 1986 The Royal Society of Medicine colorectal carcinoma is attracting a lot of critical thought nowadays. J Pou from Barcelona felt that where suture line recurrences presented with symptoms, a second operation was rarely helpful. He therefore advised colonoscopy at six-monthly intervals for the first two years to detect recurrence at an early stage. A Sitges-Creus, while agreeing that most local recurrences occurred in the first 2 years, pointed out that occasionally they may not-appear for 6 years or more.
On the following day we turned to pelvic floor problems. Methods of studying the physiology and the subsequent findings in normal and incontinent subjects were all reviewed by J Ridocci and M Minguez from Valencia and E S Kiff from Manchester, with notably high quality pressure tracings being shown by the Spanish speakers.
When it came to the management of incontinence, there was general agreement between Spanish and British speakers that most cases could be managed by conservative means but that where these failed then postanal repair was the operation of choice, giving good results in over 70%/0 of cases. The only problem appeared to be wound healing. Perhaps it is time to consider a vertical midline incision rather than the V originally described by Sir Allan Parks. A uniquely Spanish touch came from C Magallon of Valencia, who included bullfight injuries in his series of anal sphincter trauma. It is sad to realize that only cowardly matadors come to the proctologist, the brave, full-frontal ones presumably going to the urologist.
Time was set aside for four sessions of free papers. An intriguing study by J M Pique from Barcelona showed that whereas only 40% of normal people produce methane in their colon, 90% of subjects with colon cancer are found to produce methane. In those who have had a cancer resected the percentage falls to normal, an observation which gives food for thought. Other papers ranged widely through minor anal conditions, fistula in ano and a variety of colonic problems. It is clear that Spanish colorectal practice and experience is like ours, and thatwith the help of excellent simultaneous translation facilities -we all speak the same language.
Was the meeting a success? Undoubtedly. Did anything really new come out of it? Probably not. So where does the value ofsfuch a meeting lie? Certainly in the after-hours discussion stimulated by the formal meeting. But more than this it provides the opportunity to know one's colleagues better, with time for each to settle into and reveal their own individual field of excellence. Some become respected for their wisdom, some for their know, ledge, some for their imaginative flair, some for their wit, and all for their friendliness. And none of these qualities should be underrated.
The Section is the only coloproctology body in the UK, and as such has both power an-d l responsibility. Its responsibility is to-disseminate and stimulate thought amongst its own members and its friends. One can hardly think of a more enjoyable way of fulfilling this responsibility than the meeting in Barcelona. The Section is grateful to Tony SitgesCreus for the invitation and-the opportunity to do so. 
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